A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis
Authors
Keywords
Cryptosporidium parvum, Oocysts, Cryptosporidium, Cryptosporidiosis, Mouse models, Library screening, Drug therapy, Host cells
Journal
PLoS Neglected Tropical Diseases
Volume 11, Issue 2, Pages e0005373
Publisher
Public Library of Science (PLoS)
Online
2017-02-04
DOI
10.1371/journal.pntd.0005373
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mode of Action of Clofazimine and Combination Therapy with Benzothiazinones against Mycobacterium tuberculosis
- (2015) Benoit Lechartier et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- State-dependent blocking mechanism of Kv1.3 channels by the antimycobacterial drug clofazimine
- (2015) Malika Faouzi et al. BRITISH JOURNAL OF PHARMACOLOGY
- A Proposed Target Product Profile and Developmental Cascade for New Cryptosporidiosis Treatments
- (2015) Christopher D. Huston et al. PLoS Neglected Tropical Diseases
- Prevalence of Cryptosporidium parvum/hominis, Entamoeba histolytica and Giardia lamblia among Young Children with and without Diarrhea in Dar es Salaam, Tanzania
- (2015) Marit G. Tellevik et al. PLoS Neglected Tropical Diseases
- Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED)
- (2015) James A Platts-Mills et al. Lancet Global Health
- Identification of Cryptosporidium parvum Active Chemical Series by Repurposing the Open Access Malaria Box
- (2014) K. Bessoff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Validation of IMP Dehydrogenase Inhibitors in a Mouse Model of Cryptosporidiosis
- (2013) Suresh Kumar Gorla et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Drug Repurposing Screen Reveals FDA-Approved Inhibitors of Human HMG-CoA Reductase and Isoprenoid Synthesis That Block Cryptosporidium parvum Growth
- (2013) Kovi Bessoff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Intestinal parasitic infections in children presenting with diarrhoea in outpatient and inpatient settings in an informal settlement of Nairobi, Kenya
- (2013) Cecilia Kathure Mbae et al. BMC INFECTIOUS DISEASES
- A Novel Calcium-Dependent Protein Kinase Inhibitor as a Lead Compound for Treating Cryptosporidiosis
- (2013) Alejandro Castellanos-Gonzalez et al. JOURNAL OF INFECTIOUS DISEASES
- Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study
- (2013) Karen L Kotloff et al. LANCET
- Multiscale Distribution and Bioaccumulation Analysis of Clofazimine Reveals a Massive Immune System-Mediated Xenobiotic Sequestration Response
- (2012) Jason Baik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Burden of disease from cryptosporidiosis
- (2012) Debbie-Ann T. Shirley et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Infection With Cryptosporidium hominis Provides Incomplete Protection of the Host Against Cryptosporidium parvum
- (2012) Abhineet Sheoran et al. JOURNAL OF INFECTIOUS DISEASES
- The impoverished gut—a triple burden of diarrhoea, stunting and chronic disease
- (2012) Richard L. Guerrant et al. Nature Reviews Gastroenterology & Hepatology
- Identification of Putative Potassium Channel Homologues in Pathogenic Protozoa
- (2012) David L. Prole et al. PLoS One
- Macrophages Sequester Clofazimine in an Intracellular Liquid Crystal-Like Supramolecular Organization
- (2012) Jason Baik et al. PLoS One
- Novel anti-Cryptosporidium activity of known drugs identified by high-throughput screening against parasite fatty acyl-CoA binding protein (ACBP)
- (2011) J. M. Fritzler et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Clofazimine: current status and future prospects
- (2011) M. C. Cholo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Treatment of cryptosporidiosis: do we know what we think we know?
- (2010) Miguel M Cabada et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Cryptosporidiosis: environmental, therapeutic, and preventive challenges
- (2010) S. Collinet-Adler et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Prodrug Activation byCryptosporidiumThymidine Kinase
- (2010) Xin E. Sun et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitors
- (2010) Kayode K Ojo et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial
- (2009) Beatrice Amadi et al. BMC INFECTIOUS DISEASES
- Gene expression signatures and small-molecule compounds link a protein kinase to Plasmodium falciparum motility
- (2008) Nobutaka Kato et al. Nature Chemical Biology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started